Literature DB >> 7055940

More sensitive flameless atomic absorption analysis of vanadium in tissue and serum.

S D Stroop, G Helinek, H L Greene.   

Abstract

We describe a sensitive method for the determination of vanadium in biological substances by atomic absorption spectroscopy. By using background correction and pyrolytically coated graphite tubes with flameless apparatus, this vanadium assay has a sensitivity of 65 pg and a detection limit of 30 pg, approximately sixfold more sensitive than previously reported assays involving this technique. The vanadium concentrations have been determined in several biological materials, including bovine liver and human serum. To investigate signal interferences, we have determined vanadium concentrations in matrix solutions containing several elements at physiologically relevant concentrations. Evaluated by the method of standard additions, the vanadium signals are linear with concentration over a range of 3 to 100 micrograms/L. Tissue vanadium concentrations are similar to those previously reported. Serum vanadium concentrations can be determined directly, and we found values ranging from 2.22 to 3.94 micrograms/L in human serum. The improved sensitivity permits the use of sample sizes substantially smaller than previously required.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7055940

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Vanadium induced impairment of haem synthesis.

Authors:  C Missenard; G Hansen; D Kutter; A Kremer
Journal:  Br J Ind Med       Date:  1989-10

2.  Factors affecting the levels reported for vanadium in human serum.

Authors:  K Heydorn
Journal:  Biol Trace Elem Res       Date:  1990 Jul-Dec       Impact factor: 3.738

3.  Vanadium determination at the ultra-trace level in biological reference materials and serum by radiochemical neutron activation analysis.

Authors:  A R Byrne; J Versieck
Journal:  Biol Trace Elem Res       Date:  1990 Jul-Dec       Impact factor: 3.738

4.  Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus.

Authors:  J Meyerovitch; P Rothenberg; Y Shechter; S Bonner-Weir; C R Kahn
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients.

Authors:  Gail R Willsky; Katherine Halvorsen; Michael E Godzala; Lai-Har Chi; Mathew J Most; Peter Kaszynski; Debbie C Crans; Allison B Goldfine; Paul J Kostyniak
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

6.  Subchronic treatment with vanadate does not potentiate the toxicity of cardiac glycosides.

Authors:  E MacDonald; H Lihtamo; K Hellevuo; H Komulainen
Journal:  Biol Trace Elem Res       Date:  1988-08       Impact factor: 3.738

Review 7.  Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical Review.

Authors:  Thomas Scior; Jose Antonio Guevara-Garcia; Quoc-Tuan Do; Philippe Bernard; Stefan Laufer
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.